ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

N6-Methylandenosine-Related lncRNA Signature Is a Novel Biomarkers of Prognosis and Immune Response in Colon Adenocarcinoma Patients

Zhang, Peiling; Liu, Guolong*; Lu, Lin*1
Frontiers in Cell and Developmental Biology2021-7-15DOI: 10.3389/fcell.2021.703629
12被引9阅读
引用收藏
分享

摘要

Background: Colon adenocarcinoma (COAD) is the most common type of colon cancer. To date, however, the prognostic values of m6A RNA methylation-related long non-coding RNAs (lncRNAs) in COAD are largely unknown. @@@ Materials and Methods: The m6A-related lncRNAs were identified from The Cancer Genome Atlas (TCGA) data set. Univariate and multivariate Cox regression analyses were performed to explore the prognostic m6A-related lncRNAs. Consistent clustering analysis was performed to classify the COAD patients into different subgroups based on the expression of m6A-related lncRNAs. The potential biological functions as well as differences in the stemness index and tumor immune microenvironment between different subgroups were analyzed. The prognostic m6A-related lncRNAs were used to establish an m6A-related lncRNA risk model to predict prognosis and survival status. @@@ Results: We identified 31 m6A-associated lncRNAs with prognostic values from the TCGA data set. Based on the expression of prognostic m6A-associated lncRNAs, TCGA-COAD patients were classified into three clusters using consistent clustering analysis. There was a low correlation of tumor stemness between the three clusters but a significant correlation with the tumor immune microenvironment as well as the tumor mutational load. Thirty-one prognostic-related m6A-associated lncRNAs were used to construct a risk model, which was further determined by survival analysis, receiver operating characteristic (ROC) curve, and univariate and multifactor Cox analysis. The m6A-related risk model demonstrates good performance in predicting prognosis and survival status. The model-based high-risk group exhibited poorer overall survival (OS) compared with the low-risk group. @@@ Conclusion: In this study, we construct a risk model that consists of 31 m6A-related lncRNAs with independent prognostic values in COAD. Our study shows the critical roles of these 31 m6A-related lncRNAs in the tumor immune microenvironment, indicating the prospect of informing prognostic stratification and the development of immunotherapeutic strategies for COAD patients.

学科与关键词

关键词
colon adenocarcinomaM6AlncRNAtumor immune microenvironmentprognosis
相关
加载中…
  • 5mC-Related lncRNAs as Potential Prognostic Biomarkers in Colon Adenocarcinoma
    Huang, Yinghui; Huang, Huiqian; Wang, Yong; Liu, Hui*; Huang, Yingdan*Biology-Basel, 2022, 11(2): 231.被引 2
  • Identification of N6-methylandenosine related lncRNA signatures for predicting the prognosis and therapy response in colorectal cancer patients
    Li, Zhiyong; Liu, Yang; Yi, Huijie; Cai, Ting*; Wei, Yunwei*Frontiers in Genetics, 2022, 13: 947747.被引 4
  • Relationships of N6-Methyladenosine-Related Long Non-Coding RNAs With Tumor Immune Microenvironment and Clinical Prognosis in Lung Adenocarcinoma
    Zhao, Jianhui; Lin, Xi; Zhuang, Jinman; He, Fei*Frontiers in Genetics, 2021, 12: 714697.被引 15
查看全部 →

发表信息

论文状态
公开发表
期刊
Frontiers in Cell and Developmental Biology
发表日期
2021-07-15
卷期
第 9 卷
页码
703629
DOI
10.3389/fcell.2021.703629
期刊收录
NSL
期刊等级
2区
成果收录
SCIE
资助标注
Natural Science Foundation of Guangdong Province, China [2021A1515011113]; Guangzhou Science and Technology Program [201904010427]; Guangzhou General Science and technology project of Health and Family Planning [20201A011007]

作者

  • Z

    Zhang, Peiling (第一作者)

    1

  • L

    Liu, Guolong (通讯)

    1

查看全部 3 位作者收起作者
  • L

    Lu, Lin (通讯)

    1

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417